BCBS – Medical Policy Update
March 9, 2020Posted 2/14/20
- Ambulatory Event Monitors and Mobile Cardiac Outpatient Telemetry
- Artificial Intervertebral Disc: Cervical Spine
- Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast Cancer
- Automated Ambulatory Blood Pressure Monitoring for the Diagnosis of Hypertension in Patients with Elevated Office Blood Pressure
- Balloon Sinuplasty for Treatment of Chronic Sinusitis
- Cryosurgical Ablation of Miscellaneous Solid Tumors Other Than Liver, Prostate, or Dermatologic Tumors
- Dry Needling of Myofascial Trigger Points
- Dynamic Posturography
- Gene Expression Profiling and Protein Biomarkers for Prostate Cancer Management
- Gene Expression Profiling for Uveal Melanoma
- Identification of Microorganisms Using Nucleic Acid Testing
- Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
- Insulin Pump
- Measurement of Serum Antibodies to Infliximab and Adalimumab
- Positron Emission Tomography (PET) Scanning: Cardiac Applications
- Surgical Deactivation of Headache Trigger Sites
- Video EEG Monitoring
The source page for this article has moved or has expired.
Please visit the Billing Beat News or Beyond Billing Blog for relevant information or search our site for specific information related to this article.
Original source URL:
https://www.bcbsks.com/CustomerService/Providers/MedicalPolicies/policies.shtml#medicalpoliciesanchor